Your session is about to expire
← Back to Search
Behavioural Intervention
ExoNET Device for Stroke Survivors
N/A
Waitlist Available
Research Sponsored by Shirley Ryan AbilityLab
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Severe to moderate upper extremity impairment (ARAT score 0-30)
Cortical stroke with hemiparesis, tactile sensation
Must not have
Hemispatial neglect or visual field cut that prevent visual feedback
Diffuse/multiple lesion sites or multiple stroke events
Timeline
Screening 3 weeks
Treatment Varies
Follow Up treatment phases (week 1, week 2 and week 3)
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to test a robotic device called ExoNET that helps stroke patients improve their forearm movement. The study will look at whether the device is safe, effective, and easy to use.
Who is the study for?
This trial is for adult stroke survivors who need help with forearm rotation (supination). Participants must be able to give consent and follow study procedures. Specific medical conditions or treatments that might interfere with the trial are reasons for exclusion.
What is being tested?
The study tests an exoskeletal device called ExoNET, designed to assist forearm supination. There are three variations: one actually helps with movement, another provides resistance against it, and a third does nothing (sham). The goal is to see if it's safe and works as intended.
What are the potential side effects?
Since the ExoNET is a non-invasive mechanical device, side effects may include discomfort at contact points or skin irritation from wearing the device. More serious risks could involve muscle strain or joint pain due to incorrect use.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have severe to moderate difficulty using my arms and hands.
Select...
I had a stroke that affected my movement and touch on one side.
Select...
I am between 40 and 70 years old.
Select...
I can move my elbow and wrist against gravity.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have trouble seeing on one side, which affects my vision.
Select...
I have had multiple strokes or have many affected areas in my brain.
Select...
I have weakness in both sides of my body.
Select...
I have other neurological conditions.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ treatment phases (week 1, week 2 and week 3)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~treatment phases (week 1, week 2 and week 3)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Action Research Arm Test (ARAT)
Secondary study objectives
Box and Blocks
Upper extremity portion of the Fugl-Meyer (FMUE)
Other study objectives
Electromyography using Delsys
Joint Kinematics using Microsoft Kinect
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Group 2 - Sham, Assistance, Anti-AssistanceExperimental Treatment3 Interventions
Group 2 receives all three interventions in the order of sham (slack springs), then assistance, then anti-assistance. Each intervention corresponds to different settings on the device.
Group II: Group 1 - Assistance, Sham, Anti-AssistanceExperimental Treatment3 Interventions
Group 1 receives all three interventions in the order of assistance, then sham (slack springs), then anti-assistance. Each intervention corresponds to different settings on the device.
Find a Location
Who is running the clinical trial?
Shirley Ryan AbilityLabLead Sponsor
208 Previous Clinical Trials
17,995 Total Patients Enrolled
74 Trials studying Stroke
8,737 Patients Enrolled for Stroke
Share this study with friends
Copy Link
Messenger